As of Feb 05
| -0.07 / -1.95%|
The 5 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 10.50 and a low estimate of 4.00. The median estimate represents a +98.86% increase from the last price of 3.52.
The current consensus among 6 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.